LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Dasatinib
0.018333
 31.62 84.90 117 2449 0.0478 0.0684
MN20160318_Q02
I17
MCF 10A-H2B-mCherry Dasatinib
0.018333
 31.62 84.90 2839 2449 1.1589 1.0617
MN20160318_Q02
I17
MCF 10A-H2B-mCherry Dasatinib
0.018333
 33.32 84.90 111 2722 0.0408 0.0550
MN20160318_Q02
E19
MCF 10A-H2B-mCherry Dasatinib
0.018333
 33.32 84.90 2241 2722 0.8232 0.9237
MN20160318_Q02
E19
MCF 10A-H2B-mCherry Dasatinib
0.018333
 33.32 84.90 131 2722 0.0481 0.0906
MN20160318_Q02
I17
MCF 10A-H2B-mCherry Dasatinib
0.018333
 33.32 84.90 3028 2722 1.1123 1.0430
MN20160318_Q02
I17
MCF 10A-H2B-mCherry Dasatinib
0.018333
 35.03 84.90 108 2991 0.0361 0.0480
MN20160318_Q02
E19
MCF 10A-H2B-mCherry Dasatinib
0.018333
 35.03 84.90 2414 2991 0.8070 0.9183
MN20160318_Q02
E19
MCF 10A-H2B-mCherry Dasatinib
0.018333
 35.03 84.90 162 2991 0.0542 0.1340
MN20160318_Q02
I17
MCF 10A-H2B-mCherry Dasatinib
0.018333
 35.03 84.90 3279 2991 1.0962 1.0361
MN20160318_Q02
I17
MCF 10A-H2B-mCherry Dasatinib
0.018333
 36.73 84.90 109 3254 0.0335 0.0487
MN20160318_Q02
E19
MCF 10A-H2B-mCherry Dasatinib
0.018333
 36.73 84.90 2564 3254 0.7879 0.9114
MN20160318_Q02
E19
MCF 10A-H2B-mCherry Dasatinib
0.018333
 36.73 84.90 192 3254 0.0590 0.1678
MN20160318_Q02
I17
MCF 10A-H2B-mCherry Dasatinib
0.018333
 36.73 84.90 3548 3254 1.0902 1.0331
MN20160318_Q02
I17
MCF 10A-H2B-mCherry Dasatinib
0.018333
 38.43 84.90 135 3459 0.0390 0.0906
MN20160318_Q02
E19
MCF 10A-H2B-mCherry Dasatinib
0.018333
 38.43 84.90 2685 3459 0.7761 0.9074
MN20160318_Q02
E19
MCF 10A-H2B-mCherry Dasatinib
0.018333
 38.43 84.90 203 3459 0.0587 0.1770
MN20160318_Q02
I17
MCF 10A-H2B-mCherry Dasatinib
0.018333
 38.43 84.90 3744 3459 1.0822 1.0298
MN20160318_Q02
I17
MCF 10A-H2B-mCherry Dasatinib
0.018333
 40.14 84.90 179 3682 0.0486 0.1470
MN20160318_Q02
E19
MCF 10A-H2B-mCherry Dasatinib
0.018333
 40.14 84.90 2949 3682 0.8009 0.9200
MN20160318_Q02
E19
MCF 10A-H2B-mCherry Dasatinib
0.018333
 40.14 84.90 247 3682 0.0671 0.2170
MN20160318_Q02
I17
MCF 10A-H2B-mCherry Dasatinib
0.018333
 40.14 84.90 3980 3682 1.0809 1.0288
MN20160318_Q02
I17
MCF 10A-H2B-mCherry Dasatinib
0.018333
 41.84 84.90 153 4003 0.0382 0.1118
MN20160318_Q02
E19
MCF 10A-H2B-mCherry Dasatinib
0.018333
 41.84 84.90 3099 4003 0.7742 0.9100
MN20160318_Q02
E19
MCF 10A-H2B-mCherry Dasatinib
0.018333
 41.84 84.90 275 4003 0.0687 0.2354
MN20160318_Q02
I17